潘特拉辛3对克罗恩氏病表型的影响
Anna Kofla-Dlubacz1, Lilla Pawlik-Sobecka2, Tomasz Pytrus1
12nd Clinical Department of Paediatrics, Gastroenterology and Nutrition, Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland.
International journal of molecular sciences
|November 9, 2024
概括
与炎症性 (B1) 类型相比,Pentraxin 3 (PTX3) 水平在克罗恩病的狭窄性 (B2) 形式中显着更高. 这一发现表明PTX3可能作为克罗恩病患者组织重塑和纤维化的标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 生物化学 生物化学
背景情况:
- 潘特拉辛3 (PTX3) 是一种急性阶段蛋白质,对免疫反应调节和炎症信号传递至关重要.
- PTX3识别了与损伤相关的分子模式 (DAMPs),在伤口愈合中发挥作用,并可能与纤维化严重程度相关联.
- 克罗恩氏病 (CD) 是一种慢性炎症性肠病,其特征是不同的表型,包括炎症和狭窄的形式.
研究的目的:
- 调查Pentraxin 3 (PTX3) 作为克罗恩病狭窄性 (B2) 形式的表型标记物的潜力.
- 评估PTX3度与CD患者疾病表型之间的相关性.
主要方法:
- 一项涉及63名克罗恩病患者的研究,分为炎症性 (B1) 和狭窄性 (B2) 表型.
- 在患者和对照组中测量血清Pentraxin 3 (PTX3) 度.
- 统计分析用于在不同CD表型和对照中比较PTX3水平.
主要成果:
- 平均PTX3度为B1的3.06 ng/mL,B2的4.89 ng/mL,对照组的3.04 ng/mL.
- 与炎症性 (B1) 类型相比,狭窄性 (B2) 类型的PTX3水平显著更高 (p < 0.001).
- 在B2组中,PTX3度最高,在对照组中最低.
结论:
- 在克罗恩氏病的狭窄形式中,得素3 (PTX3) 水平升高,这表明它作为潜在的表型标记物的作用.
- PTX3可能参与组织重塑和纤维化发育,这是狭窄性CD表型的特征.
- 对PTX3的进一步研究可能有助于监测疾病进展和克罗恩病的治疗策略.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Inflammatory Bowel Disease II: Crohn's Disease
186
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
186
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
96
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
96
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
319
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
319
Inflammatory Bowel Disease IV: Pharmacological Management
114
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
114


